We strongly believe that the cost of medical devices should not create undue burden on families managing diabetes or prevent people from accessing care that may improve their health. As diabetes technology is rapidly advancing, we work to ensure policies are in place on the national and international level to support acceleration to market and increase accessibility.
Restrictions on coverage that impact accessibility persist in many countries, regardless of health care system design. We strive to offer innovative options that enable greater access to our products. We offer a Financial Assistance Program in the U.S. and help our customers navigate the process. We also collaborate with global government agencies and health organizations to promote an approach that offers value to healthcare systems in both the short and long term.
Learn about our Financial Assistance Program.